Indian Pharmaceuticals & Biotech Stable Growth Stocks

Ajanta Pharma

Market Cap: ₹438.0b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Emcure Pharmaceuticals

Market Cap: ₹378.9b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Neuland Laboratories

Market Cap: ₹294.5b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹265.8b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Eris Lifesciences

Market Cap: ₹192.7b

Provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally.

Granules India

Market Cap: ₹213.2b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

Lupin

Market Cap: ₹1.0t

Operates as a pharmaceutical company in India, the United States, and internationally.

Caplin Point Laboratories

Market Cap: ₹199.5b

Engages in the development, production, marketing, and export of generic formulations and branded products in India.

Sai Life Sciences

Market Cap: ₹306.4b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Aether Industries

Market Cap: ₹216.9b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Aurobindo Pharma

Market Cap: ₹954.0b

A pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.

Rubicon Research

Market Cap: ₹274.0b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Abbott India

Market Cap: ₹595.2b

Operates as a pharmaceutical company in India.

Anthem Biosciences

Market Cap: ₹502.2b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

Biocon

Market Cap: ₹689.9b

Manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹439.9b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.